MedTech Innovator Asia Pacific has announced the 20 companies selected for the 2026 MedTech Innovator Asia Pacific Accelerator Program, following the conclusion of its 2026 Pitch Events RoadTour.
The selected companies were chosen following a rigorous review and pitch process, with participating startups evaluated by a network of corporate partners, industry experts, investors, clinicians and healthcare leaders.
The 2026 cohort represents a broad range of innovations across medical devices, in vitro diagnostics, and digital health, including AI-enabled healthcare, surgical technologies, patient monitoring, and other high-impact areas.
The selected companies will now join the MedTech Innovator Asia Pacific accelerator journey, gaining access to tailored mentorship, industry connections, investor visibility and programming designed to support market readiness and long-term growth.
Selected 2026 APAC Accelerator Program Cohort Companies
MedTech Innovator Asia Pacific also announced the companies selected for the 2026 U.S. Market Access Cohort, a dedicated programme track designed to help Singapore-based medtech startups better understand and prepare for entry into the U.S. healthcare market.
Through targeted bespoke programming, expert 1:1 guidance, and ecosystem exposure, participating companies will explore key considerations across commercialisation, customer discovery, reimbursement, regulatory strategy, and investor engagement as they refine their U.S. market access plans.
Selected 2026 U.S. Market Access Cohort Companies
MedTech Innovator Asia Pacific also highlighted MedTech Spotlight Singapore, co-organised with BLOCK71 Singapore, which brought together 30 startups for a pitch event focused on medtech and healthcare innovations from across the region.
With 70% of participating startups flying into Singapore to pitch in person, the event reflected the momentum behind APAC’s medtech innovation ecosystem and the continued value of face-to-face engagement with judges, partners, investors and industry leaders.
The programme featured startup pitch sessions, a market discovery tour, and a public conference, offering participating companies multiple opportunities to present, learn, and engage with Singapore’s medtech ecosystem.
Across the pitch sessions, startups gained visibility, practical feedback and guidance from experienced judges.
As part of the market discovery tour, startups visited SingHealth and A.L.I.C.E., followed by Co11ab and NHG. The tour also included a panel discussion with Shikharesh Das from Ontogenix and Srikant Lal from regional medtech distributor IDS Medical Systems, as well as networking with healthcare and industry stakeholders.
The public conference featured two focused discussions. The investor panel, “What Gets Funded Now”, featured Anand Govindaluri from Govin Capital, Colin Tan from Coronet Ventures, and Dexter Tiah from NUS Enterprise, exploring what makes APAC medtech startups investable in a more selective funding environment.
The alumni panel, “Global Growth Playbook”, featured Elson Yong from CareCam, Ivan Toh from QuantumTx, and Arun Sethuraman from Crely Inc, sharing founder perspectives on entering new healthcare markets, building partnerships, navigating regulatory pathways, and scaling internationally.
The event concluded with a networking reception, bringing together startups, judges, speakers, partners, and ecosystem leaders for continued conversations and new connections.
The next phase of the programme includes the Innovator Summit in San Francisco, the Virtual Accelerator Program, and the 2026 Showcase & Grand Finals on 26 October 2026.
